We are live on
!
Find out more
Squarepoint Portfolio holdings
AUM
$85.1B
1-Year Est. Return
20.93%
This Fund
S&P 500
This Quarter
Est. Return
+7.16%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$7.42B
AUM Growth
+$1.24B
(+20%)
Cap. Flow
+$985M
Cap. Flow
% of AUM
13.27%
Top 10 Holdings %
Top 10 Hldgs %
10.68%
Holding
3,037
New
854
Increased
791
Reduced
777
Closed
600
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$49.3M |
| 2 |
Intuit
INTU
|
+$48.7M |
| 3 |
Costco
COST
|
+$47.9M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$47.4M |
| 5 |
Vanguard Real Estate ETF
VNQ
|
+$45.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$41M |
| 2 |
Dollar General
DG
|
+$39M |
| 3 |
Biogen
BIIB
|
+$36.8M |
| 4 |
iShares US Real Estate ETF
IYR
|
+$29.8M |
| 5 |
Waste Management
WM
|
+$29.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.19% |
| 2 | Consumer Discretionary | 16.12% |
| 3 | Healthcare | 11.21% |
| 4 | Financials | 10.17% |
| 5 | Industrials | 9.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2076
Beam Global
BEEM
$22.4M
| $205K | ﹤0.01% |
+16,852
| New | +$212K |
|
2077
BGC Group
BGC
$5.58B
| $205K | ﹤0.01% |
85,416
-152,475
| -64% | -$398K |
|
2078
Enerpac Tool Group
EPAC
$1.77B
| $205K | ﹤0.01% |
10,890
-57,273
| -84% | -$1.14M |
|
|
FUV
2079
DELISTED
Arcimoto, Inc. Common Stock
FUV
| $205K | ﹤0.01% |
+1,561
| New | +$199K |
|
|
FPAY
2080
DELISTED
FlexShopper
FPAY
| $204K | ﹤0.01% |
115,154
+93,610
| +435% | +$160K |
|
2081
NETGEAR
NTGR
$669M
| $204K | ﹤0.01% |
6,620
-35,395
| -84% | -$1.07M |
|
|
NTUS
2082
DELISTED
Natus Medical Inc
NTUS
| $204K | ﹤0.01% |
11,911
-7,042
| -37% | -$133K |
|
2083
CALL
Amgen
AMGN
$203B
| $203K | ﹤0.01% |
+800
| New | +$198K |
|
|
2084
PUT
Amgen
AMGN
$203B
| $203K | ﹤0.01% |
+800
| New | +$198K |
|
2085
DXP Enterprises
DXPE
$2.62B
| $203K | ﹤0.01% |
12,556
-12,181
| -49% | -$225K |
|
2086
Employers Holdings
EIG
$908M
| $203K | ﹤0.01% |
+6,726
| New | +$213K |
|
2087
Upbound Group
UPBD
$1.19B
| $203K | ﹤0.01% |
6,800
-14,600
| -68% | -$432K |
|
|
FTIVU
2088
DELISTED
FinTech Acquisition Corp. IV Unit
FTIVU
| $203K | ﹤0.01% |
+20,000
| New | +$205K |
|
|
TUFN
2089
DELISTED
Tufin Software Technologies Ltd.
TUFN
| $202K | ﹤0.01% |
+24,496
| New | +$238K |
|
2090
CALL
Nike
NKE
$61.9B
| $201K | ﹤0.01% |
+1,600
| New | +$172K |
|
2091
Tidewater
TDW
$3.91B
| $201K | ﹤0.01% |
30,011
-34,288
| -53% | -$225K |
|
2092
Heritage Insurance Holdings
HRTG
$842M
| $200K | ﹤0.01% |
19,745
-26,310
| -57% | -$325K |
|
2093
WidePoint Corp
WYY
$104M
| $200K | ﹤0.01% |
+39,980
| New | +$254K |
|
|
CNCE
2094
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $200K | ﹤0.01% |
+20,393
| New | +$201K |
|
2095
Mistras Group
MG
$492M
| $199K | ﹤0.01% |
51,018
+38,592
| +311% | +$155K |
|
2096
Puma Biotechnology
PBYI
$406M
| $199K | ﹤0.01% |
19,703
+3,045
| +18% | +$31K |
|
|
CDTX
2097
DELISTED
Cidara Therapeutics
CDTX
| $198K | ﹤0.01% |
3,474
-988
| -22% | -$69.8K |
|
2098
Enviri
NVRI
$621M
| $198K | ﹤0.01% |
14,212
-7,008
| -33% | -$101K |
|
|
VRS
2099
DELISTED
Verso Corporation
VRS
| $198K | ﹤0.01% |
25,099
-20,460
| -45% | -$249K |
|
|
BRFS
2100
DELISTED
BRF SA
BRFS
| $197K | ﹤0.01% |
+59,990
| New | +$230K |
|
Similar funds
Squarepoint's Q3 2020 Portfolio in Review
As of Q3 2020, Squarepoint held 3,037 positions worth $7.42B, up 20% from $6.18B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Squarepoint deployed $985M of net new capital in Q3 2020, opening 854 new positions and adding to 791 existing holdings. Its largest new stake was Salesforce: 186,017 shares worth $46.8M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Pfizer, an estimated $41M trimmed.
- Squarepoint's largest Q3 2020 buy was Salesforce: 186,017 shares worth $46.8M.
- Squarepoint added most to Visa in Q3 2020, an estimated $49.3M increase.
- Squarepoint's biggest Q3 2020 reduction was Pfizer, cutting an estimated $41M.
- Squarepoint fully exited Biogen in Q3 2020, selling an estimated $36.8M.
- Squarepoint's ten largest holdings make up 11% of its $7.42B portfolio in Q3 2020.
- Squarepoint opened 854 new positions and closed 600 in Q3 2020.
- Squarepoint's portfolio value rose 20% quarter-over-quarter to $7.42B.
Based on Squarepoint's 13F filing for Q3 2020, filed 16 Nov 2020.